SCHEMBL20408699

SCHEMBL20408699

Cc1ccccc1S(=O)(=O)N1CCN(C(=O)OC(C)C(F)(F)F)CC1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ ALDH1A1 P00352 5/20 0.43
▸ SMN1; SMN2 Q16637 3/20 0.43
▸ TSHR P16473 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ TP53 P04637 1/20 0.42
▸ EPHX2 P34913 1/20 0.42
▸ F13A1 P00488 1/20 0.41
▸ TGM2 P21980 1/20 0.41
▸ TGM1 P22735 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ PKM P14618 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15100855 0.89 MGLL (0.50) LMNAHSD17B10ALDH1A1SMN1; SMN2TSHR
SCHEMBL18634077 0.86 LMNA (0.44) LMNAHSD17B10ALDH1A1SMN1; SMN2TSHR
SCHEMBL20408695 0.84 GAA (0.56) LMNAALDH1A1SMN1; SMN2GAAKMT2A
SCHEMBL20408697 0.81 KMT2A (0.57) LMNAALDH1A1SMN1; SMN2KDM4EGAA
SCHEMBL20408696 0.79 GPR183 (0.52) LMNASMN1; SMN2GAAKMT2AMEN1
SCHEMBL20408703 0.79 PKM (0.65) LMNAALDH1A1SMN1; SMN2GAAHTT
SCHEMBL20408701 0.76 SMN1; SMN2 (0.62) LMNASMN1; SMN2GAAHPGDHTT
SCHEMBL18701958 0.76 EPHX2 (0.49) LMNAHSD17B10ALDH1A1SMN1; SMN2GAA
SCHEMBL15830167 0.76 ALDH1A1 (0.53) LMNAHSD17B10ALDH1A1SMN1; SMN2GAA
SCHEMBL5369302 0.75 CYP3A4 (0.59) LMNAALDH1A1SMN1; SMN2TSHRGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208568-A1 CARBAMATE COMPOUNDS AND METHODS OF MAKING AND USING SAME H. LUNDBECK A/S (DK) 2018-07-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180208568-A1 CARBAMATE COMPOUNDS AND METHODS OF MAKING AND USING SAME ABHD6, ABHD16A, NCEH1 LMNA 4712/4885HSD17B10 1408/4885ALDH1A1 1712/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback